Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study. (2013)
Attributed to:
Fuse, the Centre for Translational Reseach in Public Health (renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/ner.12003
PubMed Identifier: 23205907
Publication URI: http://europepmc.org/abstract/MED/23205907
Type: Journal Article/Review
Volume: 16
Parent Publication: Neuromodulation : journal of the International Neuromodulation Society
Issue: 6
ISSN: 1094-7159